Pelotonia riders cycle for research

Article

Audrey Rabalais, a senior journalism major at Ohio University, is a summer editorial intern with CURE. Although cyclist and cancer survivor Lance Armstrong does his most renowned riding in France, he received a warm welcome when he pedaled into Athens last year: Athens, Ohio, to be clear. Armstrong was the spokesman for the inaugural Pelotonia bicycle tour, a 180-mile ride that raised $4.5 million in 2009 for cancer research at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James).The grassroots bicycle tour was the brainchild of Michael Caligiuri, MD, director of the OSUCCC and CEO of The James. Looking for sources of funding for the cancer center, Caligiuri was inspired by the Pan-Mass Challenge, a cycling event that raises money for the Dana-Farber Cancer Institute in Boston. The Pelotonia was then created, the name stemming from peloton, the term for the main group of riders in a cycling race.Unlike runners, cyclists aim to stay as close as possible to one another, as this reduces wind resistance and makes travel more efficient. Although the Pelotonia is not a race, the idea of working as an efficient team applies to the goal of curing cancer – 100 percent of every dollar raised by teams and individuals in the Pelotonia goes toward cancer research. Last year's ride drew 2,265 cyclists from 31 states. This year, there are over 4000 registered entries for the Pelotonia website. The 2010 route will be the same as last year, beginning at Ohio State University's Chemical Abstracts building and, for those who ride the entire route, finishing outside Ohio University's Convocation Center on the first day. Riders then spend the night in Athens and ride back to Columbus the following day. I happened to be in Athens during the race last year, as I was a Resident Assistant in the Convocation Center which, in addition to being a basketball arena, houses a circular residence hall. The hype surrounding the arrival of the riders was tangible, as tents and a band stand were set up earlier in the day. Some of the riders stayed in the dorms overnight and the parking garage was filled with well-used road bikes. In a town with just one main road, an event like this is exciting, especially when the cause is an incredibly worth one.The money raised from last year is currently funding research for pancreatic cancer prevention, triple-negative breast cancer therapies, a new leukemia drug, and the role of heredity in cancer development. If as much or more money is raised this year, who knows what new research is on the horizon for the cancer center.This year's race is August 20 to the 22nd, and it's not too late to sign up! In addition to helping fund cancer research, wouldn't it be great to say that you rode with Lance Armstrong?

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content